Bacterial prostatitis: Treatment with carbenicillin indanyl sodium

Research output: Contribution to journalArticle

9 Scopus citations

Abstract

The efficacy and safety of carbenicillin indanyl sodium were evaluated in 16 patients with acute or chronic bacterial prostatitis. Each patient received carbenicillin indanyl sodium (Geocillin) tablets, at a dosage of two 500 mg tablets (each tablet equivalent to 382 mg of carbenicillin) four times daily for either 14 days (acute patients) or 28 days (chronic patients). Clinical and bacteriologic success rates, based upon 4 week post-therapy follow-up, were 93% and 75%, respectively. There were no adverse reactions. Results with cephalexin in a concurrently treated alternative therapy group were generally unsatisfactory. Further evaluations of carbenicillin indanyl sodium in this treatment of resistant populations are clearly warranted.

Original languageEnglish (US)
Pages (from-to)31-33
Number of pages3
JournalInvestigative Urology
Volume19
Issue number1
StatePublished - Jan 1 1981

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Bacterial prostatitis: Treatment with carbenicillin indanyl sodium'. Together they form a unique fingerprint.

Cite this